Oncolytics Biotech Inc. (ONCY)

Oncolytics Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.64	5.2	11.08	34.91	11.67	41.26
Short-Term Investments	-	-	-	-	20.47	-
Cash & Short-Term Investments	7.64	5.2	11.08	34.91	32.14	41.26
Cash Growth	-50.09%	-53.05%	-68.27%	8.63%	-22.11%	32.17%
Other Receivables	1.34	0.57	0.05	0.02	0.52	0.87
Total Trade Receivables	1.34	0.57	0.05	0.02	0.52	0.87
Other Current Assets	1.44	1.07	1.31	3.25	3.03	2.78
Total Current Assets	10.41	6.84	12.44	38.17	35.68	44.9
Net Property, Plant & Equipment	0.94	0.74	0.99	0.65	0.65	0.98
Other Long-Term Assets	-	-	-	-	1	-
Total Assets	11.35	7.58	13.42	38.82	37.33	45.88

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.73	3.5	0.76	3.57	3.65	1.99
Accrued Expenses	3.58	2.33	2.57	-	-	-
Current Portion of Leases	0.23	0.19	0.2	0.13	0.22	0.29
Other Current Liabilities	-	0.08	1.36	0.53	0.08	0.41
Total Current Liabilities	7.54	6.1	4.89	4.24	3.95	2.69
Long-Term Leases	0.48	0.37	0.56	0.29	0.16	0.36
Other Long-Term Liabilities	10.46	4.91	4.68	6.73	6.73	6.73
Total Long-Term Liabilities	10.94	5.28	5.24	7.02	6.89	7.09
Total Liabilities	18.48	11.38	10.12	11.26	10.83	9.78

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	-	-	-	430.91	404.04	391.35
Additional Paid-in Capital	594.19	419.47	397.67	42.12	40.05	37.78
Accumulated Other Comprehensive Income	8.65	6.23	6.36	0.54	0.66	0.39
Retained Earnings	-609.98	-429.5	-400.74	-446	-418.25	-393.42
Shareholders' Equity	-7.13	-3.8	3.3	27.56	26.5	36.1
Total Liabilities & Equity	11.35	7.58	13.42	38.82	37.33	45.88

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.71	0.56	0.76	0.42	0.37	0.66
Net Cash (Debt)	6.93	4.64	10.32	34.49	31.77	40.61
Net Cash Growth	-51.54%	-55.04%	-70.08%	8.58%	-21.77%	31.77%
Net Cash Per Share	0.07	0.05	0.14	0.51	0.55	0.76
Book Value	-7.13	-3.8	3.3	27.56	26.5	36.1
Book Value Per Share	-0.07	-0.04	0.04	0.41	0.46	0.67
Tangible Book Value	-7.13	-3.8	3.3	27.56	26.5	36.1
Tangible Book Value Per Share	-0.07	-0.04	0.04	0.41	0.46	0.67

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 14, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error